UW Department of Psychiatry

7th Annual Update and Advances in Psychiatry Conference
2019-10-11 07:30 - 2019-10-12 12:00 (America/Chicago) | Monona Terrace, 1 John Nolen Dr, Madison, WI, 53703, United States
REGISTER VIA ICEP PORTAL:
https://ce.icep.wisc.edu/2019-Annual-Update#group-tabs-node-course-default6

Available credit:

9.00 AMA PRA Category 1 Credit™
9.00 University of Wisconsin–Madison Continuing Education Hours

STATEMENT OF NEED
This activity is being held in response to mental health professionals’ previous conference evaluations and the need for ongoing continuing medical education for clinicians in the area of psychiatry.
ELEMENTS OF COMPETENCE
This CME activity has been designed to change learner competence and focuses on the American Board of Medical Specialties’ areas of medical knowledge and patient care and procedural skills.

TARGET AUDIENCE

This educational activity has been designed to meet the needs of clinicians and other health care professionals who are looking to enhance their knowledge and skills for the care of their patients with mental health issues.

LEARNING OBJECTIVES

At the conclusion of this educational activity, participants should be able to:

Describe the data supporting efficacy and risks associated with transcranial magnetic stimulation in the treatment of major depressive disorder
Develop a plan to address substances use disorders in their patients who are children or adolescents
Manage the challenges associated with caring for patients with personality disorders
Summarize how to balance working with children and their parents in the context of divorce
List the most recently developed and discovered drugs of abuse, and their psychiatric sequelae
Develop a plan to screen for, diagnose, and treat bipolar disorder in their older adult patients
Develop and implement a treatment plan for their patients with obsessive-compulsive disorder
Appreciate the clinical and research links between substance use disorders and eating disorders
Describe the steps that health care providers can take to promote wellness within their institutions

FRIDAY, OCTOBER 11

7:15
Registration and Continental Breakfast

8:00
Welcome
Ned Kalin, MD & Art Walaszek, MD

8:45
Role of TMS in the Treatment of Major Depressive Disorder
Linda L. Carpenter, MD

9:45
Q & A
Moderator: Ned Kalin, MD

10:15
Refreshment Break

10:30
An Update on the Treatment of Substance Use Disorders in Adolescents
Justine W. Welsh, MD

11:30
Q & A
Moderator: Ned Kalin, MD

12:00
Lunch

1:00
Breakout Sessions & Case Discussions
1) Strategies for Caring for Patients with Personality Disorders – Erri Hewitt, PhD
2) Providing Mental Health Care to Children with Divorced Parents – Jason Horowitz, PhD
3) New Drugs the Kids are Using These Days – Jennifer McDonald, MD
4) Recognizing and Treating Bipolar Disorder in Older Adults – Eileen Ahearn, MD

2:30
Refreshment Break

2:45
In Memoriam – James W. “Jeff” Jefferson
John H. Greist, MD; Ned Kalin, MD; & Art Walaszek, MD

3:00
Inaugural James W. Jefferson Lecture
Optimal Treatment of Obsessive-Compulsive Disorder
John H. Greist, MD

4:00
Q & A
Moderator: Ned Kalin, MD

4:30
Adjourn

SATURDAY, OCTOBER 12

7:45
Registration and Continental Breakfast

8:25
Introduction
Ned Kalin, MD & Art Walaszek, MD

8:30
My Career in Translational Addiction Research: From Opioids, to Cocaine, to Food
Mark S. Gold, MD

9:30
Q & A
Moderator: Art Walaszek, MD

10:00
Refreshment Break

10:15
The Long Game: Stories of Our Lives in Medicine
Helping students, trainees and physicians create and sustain satisfying careers
Joan M. Anzia, MD

11:15
Q & A
Moderator: Art Walaszek, MD

11:45
Adjourn

Charles B. Nemeroff, MD, PhD | UW Psychiatry Grand Rounds
2019-09-20 12:00 - 13:00 (America/Chicago) | Webex
Prediction of Disease Vulnerability and Treatment Response in Mood Disorders and PTSD: Personalized Medicine in Psychiatry

FRIDAY SEPT 13 | 12:00pm
WisPIC Commons Room 1616
6001 Research Park Blvd
Charles B. Nemeroff, MD, PhD
Chair and Professor of Psychiatry
Director, Institute for Early Childhood Adversity Research
University of Texas at Austin – Dell Medical School
Learning Objectives

To understand the principles of personalized medicine as applied to mood and anxiety disorders.
To understand the role of Genome Wide Association Studies (GWAS), candidate gene approaches, transcriptomics, epigenetics, and proteomics in predicting disease treatment response in mood and anxiety disorders.
To understand the potential for functional brain imaging for predicting treatment response in mood and anxiety disorders.
To understand the role of gene-environment interactions, particularly early life trauma, in predicting treatment response in mood disorders.

Charles B. Nemeroff, MD, PhD, is a Professor of Psychiatry and Acting Chair of the Department of Psychiatry. He is also Associate Chair of Research, and the Director of the Institute for of Early Life Adversity Research at Dell Medical School at the University of Texas at Austin.
He received his MD and PhD (Neurobiology) degrees from the University of North Carolina UNC) School of Medicine in Chapel Hill, North Carolina. After psychiatry residency training at UNC and Duke University, he held faculty positions at Duke University and was Chair of the Department of Psychiatry and Behavioral Sciences at Emory University for 18 years before relocating to the University of Miami in 2009.
He has served as President of the American College of Psychiatrists (ACP) and the American College of Neuropsychopharmacology (ACNP) and sits on the Scientific Advisory Board and Board of Directors of the American Foundation for Suicide Prevention (AFSP) and the Anxiety and Depression Association of America

He has received a number of research and education awards including the Kempf Award in Psychobiology, the Samuel Hibbs Award, Research Mentoring Award,Judson Marmot Award and the Vestermark Award from the American Psychiatric Association (APA), the Mood Disorders Award, Bowis Award and Dean Award from the ACP and the Julius Axelrod Award for mentoring from the ACNP. He was elected to the Institute of Medicine (now the National Academy of Medicine) of the National Academy of Sciences in 2002.
He has been named Alumnus of the Year from the University of North Carolina (UNC) and from the UNC Medical School. He received the Doctorate Honoris Causa from Maimonides University in Buenos Aires in 2015.
His research has focused on the pathophysiology of mood and anxiety disorders with a focus on the role of child abuse and neglect as a major risk factor. He has also focused on the role of mood disorders as a risk factor for major medical disorders including heart disease, diabetes and cancer. He has published more than 1100 research reports and reviews.
He has served on the Mental Health Advisory Council of NIMH and the Biomedical Research Council for NASA. He is the co-editor in chief (with Alan F. Schatzberg, MD.) of the Textbook of Psychopharmacology, published by the APA Press, now in its Fifth Edition.
His research is currently supported by grants from the NIH.

Greenfield Memorial Lecture: Progress in Suicide Prevention | Charles B. Nemeroff, MD, PhD
2019-09-12 17:00 - 19:00 (America/Chicago) | Webex
Progress in Suicide Prevention
THURSDAY, SEPTEMBER 12, 2019
5:30 – 7:00PM
Wisconsin Psychiatric Institute and Clinic
6001 Research Park Boulevard, Room 1616
* Light refreshments will be served *
Charles B. Nemeroff, MD, PhD
Professor and Acting Chair
Department of Psychiatry
Associate Chair for Research
Director, Institute of Early Life Adversity Research
Dell Medical School, The University of Texas at Austin

Suicide is the 10th leading cause of death in the United States, the only one of the top ten that is increasing in number year after year. This year there will likely be 50,000 suicides in the United States (130 per day) and in addition approximately 20,000 of the 70,000 opiate overdose deaths each year are classified as suicides. It is the second leading cause of death in the 15-34 year age group. In spite of many public health and education efforts in the past decade, suicide rates have continued to climb. Research on risk factors for suicide have been informative. Men are at significantly greater risk for suicide than women. In addition other risk factors that have been clearly documented are a past diagnosis of depression or related psychiatric disorders, history of childhood maltreatment including bullying, family history of suicide (underlying the genetic component of risk), alcohol and substance abuse, as well as more recent life stressors such as loss of job, a recent serious medical diagnosis, imminent divorce and recent trauma. The reduction of available psychiatric inpatient beds is also associated with the year over year increase nationally. There is considerable evidence for an underlying neurobiological basis for suicidality including increased inflammation, decreased activity of serotonergic circuits in the brain and increase activity of the major mammalian stress system, the pituitary-adrenal axis. Certain medications including lithium and clozapine are known to reduce suicide as are certain forms of cognitive-behavioral therapy (CBT). Finally providing obstacles to means of suicide has been shown to be effective in reducing suicide rates.

Charles B. Nemeroff, MD, PhD, is a Professor of Psychiatry and Acting Chair of the Department of Psychiatry. He is also Associate Chair of Research, and the Director of the Institute for of Early Life Adversity Research at Dell Medical School at the University of Texas at Austin.
He received his MD and PhD (Neurobiology) degrees from the University of North Carolina UNC) School of Medicine in Chapel Hill, North Carolina. After psychiatry residency training at UNC and Duke University, he held faculty positions at Duke University and was Chair of the Department of Psychiatry and Behavioral Sciences at Emory University for 18 years before relocating to the University of Miami in 2009.
He has served as President of the American College of Psychiatrists (ACP) and the American College of Neuropsychopharmacology (ACNP) and sits on the Scientific Advisory Board and Board of Directors of the American Foundation for Suicide Prevention (AFSP) and the Anxiety and Depression Association of America (ADAA).
He has received a number of research and education awards including the Kempf Award in Psychobiology, the Samuel Hibbs Award, Research Mentoring Award,Judson Marmot Award and the Vestermark Award from the American Psychiatric Association (APA), the Mood Disorders Award, Bowis Award and Dean Award from the ACP and the Julius Axelrod Award for mentoring from the ACNP. He was elected to the Institute of Medicine (now the National Academy of Medicine) of the National Academy of Sciences in 2002.
He has been named Alumnus of the Year from the University of North Carolina (UNC) and from the UNC Medical School. He received the Doctorate Honoris Causa from Maimonides University in Buenos Aires in 2015.
His research has focused on the pathophysiology of mood and anxiety disorders with a focus on the role of child abuse and neglect as a major risk factor. He has also focused on the role of mood disorders as a risk factor for major medical disorders including heart disease, diabetes and cancer. He has published more than 1100 research reports and reviews.
He has served on the Mental Health Advisory Council of NIMH and the Biomedical Research Council for NASA. He is the co-editor in chief (with Alan F. Schatzberg, MD.) of the Textbook of Psychopharmacology, published by the APA Press, now in its Fifth Edition.
His research is currently supported by grants from the NIH.

Additional Talk:
Friday, Sept 13 – 12:00pm | WisPIC Commons Room
Psychiatry Grand Rounds
Prediction of Disease Vulnerability and Treatment Response in Mood Disorders and PTSD: Personalized Medicine in Psychiatry

Reading List:
1. The Holy Grail of Psychiatry (2015) 81-89
2. Understanding Depression – Contemporary Issues (2017) 21, 245-261
3. Psychosomatic Medicine (2014) 76, 445-451

Heather Abercrombie, PhD | UW Psychiatry Grand Rounds
2019-08-23 12:00 - 13:15 (America/Chicago) | Webex
Neurocognitive Sensitivity to Cortisol in Depression

Heather C. Abercrombie, Ph.D.
Associate Professor (CHS)
University of Wisconsin-Madison
School of Medicine and Public Health
Department of Psychiatry

Many individuals with depression show “glucocorticoid resistance,” which reflects systemic and cellular insensitivity to the stress-related hormone cortisol. However, the neural and psychological relevance of glucocorticoid resistance is unknown. This is a huge gap in our knowledge, because basic research shows that cortisol has potent yet variable effects on psychological function. Our research addresses this knowledge gap, and we have shown that glucocorticoid resistance is related to negatively biased emotional memory and related neural circuitry. Importantly, we have also shown that cortisol augmentation ameliorates negative memory bias in depression, particularly in glucocorticoid resistant individuals. Taken together, these findings suggest that glucocorticoid resistance is related to core psychological features of depression, and that boosting cortisol signal may be psychologically beneficial in glucocorticoid resistant individuals with depression.

Learning objectives:

Debunk popular notions of cortisol as unequivocally harmful
Understand the relation between cortisol and psychological functions relevant to depression
Understand that cortisol augmentation may be beneficial in depression

Accreditation Statement
In support of improving patient care, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statement:
The University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 CEUs or 1.0 hour.

Educational Conference: Eileen P. Ahearn, MD, PhD - The Psychopharmacologic Treatment of PTSD
2019-08-21 12:00 - 13:00 (America/Chicago) | Group Room A (4th Floor) | 1102 S Park St | UW Behavioral Health & Recovery, 1102 S Park Street, Suite 400, Madison, Wisconsin, 53715
The Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee). Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty. This educational series is open to the public and anyone is welcome to attend. Continue Medical Education units (CME’s) are available to eligible attendees.

Location:
Group Room A
UW Behavioral Health & Recovery
1102 South Park Street
Madison, WI 53715

8/21/19 – Eileen P. Ahearn, MD, PhD – The Psychopharmacologic Treatment of PTSD

Accreditation Statement
In support of improving patient care, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statement:
The University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Anna Ratzliff, MD, PhD | UW Psychiatry Grand Rounds
2019-06-28 12:00 - 13:15 (America/Chicago) | Webex
Implementing Collaborative Care: Translation from Research to Real World
Anna Ratzliff, MD, PhD
Associate Professor
Depression Therapy Research Endowed Professorship
Director, AIMS Center
Director, UW Integrated Care Training Program

Learning Objectives:
1) List common barriers and facilitators to collaborative care implementation.
2) Describe five phases to implementation of collaborative care.
3) Name common factors influencing the sustainability of collaborative care.
This lecture will provide a brief overview of the collaborative care model (CoCM) and review current thinking about implementation of this approach to deliver mental health treatment in primary care settings. An approach to the five phase of implementation will be discussed including common barriers and facilitators.

Dr. Anna Ratzliff is a national expert on collaborative care and specifically, on training teams to implement and deliver mental health treatment in primary care settings. Her passion for translating complex research ideas into practical real-world applications began when she received her MD and PhD in Anatomy and Neurobiology as part of the Medical Scientist Training Program at the University of California at Irvine. She currently is an Associate Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington where she has developed expertise in suicide prevention training, mental health workforce development, adult learning best practices, and mentorship. Dr. Ratzliff is the Director of the AIMS Center (Advancing Integrated Mental Health Solutions), is the Director of the UW Integrated Care Training Program for residents and fellows, and leads a national collaborative care training program for the American Psychiatric Association’s Transforming Clinical Practices Initiative grant. For more information on collaborative care please visit the AIMS Center Website (aims.uw.edu), the UW Integrated Care Training Program (ictp.uw.edu).

Accreditation Statement
In support of improving patient care, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statement:
The University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 CEUs or 1.0 hour.

Educational Conference: Steve Garlow, MD [Topic: Transcranial Magnetic Stimulation]
2019-06-19 12:00 - 13:00 (America/Chicago) | Group Room A (4th Floor) | 1102 S Park St | UW Behavioral Health & Recovery, 1102 S Park Street, Suite 400, Madison, Wisconsin, 53715
6/19/19
Steve Garlow, MD
Topic: TMS – Transcranial Magnetic Stimulation
Title: TBD

The Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee). Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty. This educational series is open to the public and anyone is welcome to attend. Continue Medical Education units (CME’s) are available to eligible attendees.
Location:
Group Room A
UW Behavioral Health & Recovery
1102 South Park Street
Madison, WI 53715

Boris Birmaher, MD | UW Psychiatry Grand Rounds
2019-04-19 12:00 - 13:15 (America/Chicago) | Webex
*** Part of the Briskey Family Bipolar Lecture Series***
Predicting the Development of Bipolar Disorder and Mood Recurrences –
Toward Personalized Psychiatry
Boris Birmaher, MD
Endowed Chair in Early Onset Bipolar Disease and Professor of Psychiatry
Director, Child and Adolescent Bipolar Spectrum Services
Co-Director, Psychiatry Research Pathway Program
University of Pittsburgh
Learning objectives:

To describe the prodromal symptoms of bipolar disorder
To describe the course and outcome of bipolar disorder in youth and the factors associated with increases risk for recurrences
To describe the use of “risk calculators” to predict “personalized” risk to develop bipolar disorder as well as the risk of recurrences.

Dr. Birmaher is the Endowed Chair in Early Onset Bipolar Disease and Professor of Psychiatry at the University of Pittsburgh, School of Medicine and serves as the Co-Director of the Psychiatry Research Pathway program and the Director of the Child and Adolescent Bipolar Spectrum Services. He received his medical degree from Valle University in Cali, Colombia; completed training in general psychiatry at the Hebrew University in Jerusalem, Israel, and child psychiatry at Columbia University, New York.
Dr Birmaher is a leader in the study and treatment of pediatric mood and anxiety disorders. In addition, his research has concentrated in describing the predictors, risk factors, course and treatment of childhood-onset bipolar disorder. Throughout his career, he has served as the Principal, Co-Principal or co-investigator for over 25 federally-sponsored research grants and projects. He has authored or co-authored more than 430 publications, numerous book chapters as well as his own book, New Hope for Children and Teens with Bipolar Disorder. Dr. Birmaher has been the recipient of numerous awards over the years including the Colvin Prize for Outstanding Achievement in Mood Disorders Research in 2013 and the Ittleson Award for Research in Child and Adolescent Psychiatry in 2014. In 2018, he received the Gerald L Klerman Senior Investigator Award and the Lifelong Fellow Award from the American Psychiatric Association. For four years and until 10/2018 he was the Program Chair of the American Academy of Child and Adolescent Psychiatry and recently was named Counselor-At-Large of the same association. Through his research, clinical and mentoring activities, Dr. Birmaher has increased our understanding of the risk factors for mood and anxiety disorders, developed and implemented innovative treatments to improve the lives of patients and their families, and trained the next generation of educators, clinicians and researchers.

Accreditation Statement
In support of improving patient care, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statement:
The University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 CEUs or 1.0 hour.

Educational Conference: Dean Krahn, MD - Pharmacologic Management of Alcohol Use Disorders
2019-04-17 12:00 (America/Chicago) | Group Room A (4th Floor) | 1102 S Park St | UW Behavioral Health & Recovery, 1102 S Park Street, Suite 400, Madison, Wisconsin, 53715
The Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee). Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty. This educational series is open to the public and anyone is welcome to attend. Continue Medical Education units (CME’s) are available to eligible attendees.

Location:
Group Room A
UW Behavioral Health & Recovery
1102 South Park Street
Madison, WI 53715

4/17/19 – Dean Krahn, MD – Pharmacologic Management of Alcohol Use Disorders

Accreditation Statement
In support of improving patient care, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statement:
The University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Depression in Women: the Brain in Context (Public Talk) - David Rubinow, MD)
2019-04-09 17:00 - 18:00 (America/Chicago) | Health Sciences Learning Center – Auditorium (HSLC 1306), 750 Highland Avenue, Madison, WI, 53705, United States
*** This talk is free and open to the public! Please share with friends, family, and colleagues who may be interested in attending ***
To celebrate the 25th annual Wisconsin Symposium on Emotion, The University of Wisconsin Department of Psychiatry, along with the HealthEmotions Research Institute and Center for Healthy Minds are pleased to announce a free public talk by distinguished scientist and clinician, David Rubinow, MD on Tuesday, April 9th at 5:00pm in the HSLC auditorium.

One could argue that the most important question we can ask about brain and behavior is the following: why is it that different people respond differently to the same stimulus? As much as we have learned about neuroscience over the past twenty-five years, largely consequent to some of the amazing tools that have been developed, it is overwhelmingly apparent that the brain, like other organs, responds very differently to a given signal as a product of context. This context includes past exposure, sex, current environment, genetic inheritance, and hormonal state. The role of context in the regulation of brain and generation of different behavioral responses is wonderfully illustrated by examining the role of reproductive steroid hormones – estrogen and progesterone – in depression that occurs in women during periods of reproductive change: the menstrual cycle, peripartum, and perimenopausal. In this presentation, I will describe some of the technologies that allow us to peer into the brain and will illustrate how the biology of sex hormones enables us to understand how context shapes the tremendous variability in health and behavior.

Dr. David Rubinow is the Assad Meymandi Professor and Chair of the Department of Psychiatry at the University of North Carolina – Chapel Hill, School of Medicine. Prior to joining UNC, he was the Clinical Director of the National Institute of Mental Health (NIMH) and Chief of the Behavioral Endocrinology Branch. His research interests focus on neurobehavioral effects of gonadal steroids and how genetic variation contributes to differential behavioral response to changes in steroid signaling. Research methods used include administration of hormone super agonists and receptor blockers to manipulate the menstrual cycle and identify the central effects of gonadal steroids in isolation. These studies have demonstrated that, unlike mood disorders accompanying endocrinopathies, reproductive endocrine-related mood disorders represent abnormal responses to normal hormonal signals. Current NIH funded studies include investigations of continuous oral contraceptive administration in menstrual cycle-related mood disorders, estradiol effects on cardiovascular risk and mood dysregulation during the perimenopause, and biomarkers of postpartum depression. Additionally, the UNC Women’s Mood Disorders Program, which he directs, has the first and only NIH training fellowship in Women’s Mood Disorders. On the basis of his research, he was inducted into the Institute of Medicine of the National Academies in 2012. Dr. Rubinow is also the Director of the UNC Center for Innovation and Health Care System Transformation, which promotes the development of patient-centered innovations designed to address the current challenges facing our nation’s health care delivery system.

Conor Liston, MD, PhD | UW Psychiatry Grand Rounds
2019-03-08 12:00 - 13:15 (America/Chicago) | Webex
Neuroimaging Biomarkers for Diagnosing Neurophysiological Subtypes of Depression and Predicting Treatment Response

Conor Liston, MD, PhD
Assistant Professor of Neuroscience
Brain and Mind Research Institute
and Department of Psychiatry
Weill Cornell Medicine

Conor Liston, MD, PhD is an Associate Professor of Neuroscience and Psychiatry in the Feil Family Brain and Mind Research Institute and the Department of Psychiatry at Weill Cornell Medicine. The long-term goals of his research program are to define mechanisms by which prefrontal cortical brain circuits support learning, memory, and motivation, and to understand how these functions are disrupted in depression, addictions, and other stress-related psychiatric disorders. To this end, experiments in his lab integrate optogenetic tools and genetically encoded calcium indicators with two-photon imaging and functional MRI, and his team is actively developing new methods for quantifying prefrontal cortical microcircuit dynamics in genetically defined neuronal subtypes. They are also developing novel neuroimaging tools for informing psychiatric diagnosis in human populations and predicting treatment response to transcranial magnetic stimulation (TMS) and other neurostimulatory antidepressant interventions.
Dr. Liston graduated summa cum laude from Harvard College in 1998, and received his PhD and MD from The Rockefeller University and Weill Cornell Medicine in 2007 and 2008, respectively, where he was supported by a Paul and Daisy Soros Fellowship for New Americans. He subsequently completed his residency in psychiatry at New York–Presbyterian Hospital and postdoctoral training at Stanford University. He returned to Weill Cornell as an Assistant Professor in 2014. His research has been recognized with awards from the Klingenstein-Simons Foundation Fund, the Rita Allen Foundation, the Dana Foundation, the Doris Duke Charitable Foundation, and the One Mind Institute. Dr. Liston is also a clinically active psychiatrist specializing in the management of treatment-resistant mood disorders.

Accreditation Statement
In support of improving patient care, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statement:
The University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 CEUs or 1.0 hour.

Educational Conference: Ronni Hayon, MD - The "T" in LGBTQ: Providing Compassionate and Appropriate Care to TNG Patients
2019-02-20 12:00 - 13:00 (America/Chicago) | Group Room A (4th Floor) | 1102 S Park St | UW Behavioral Health & Recovery, 1102 S Park Street, Suite 400, Madison, Wisconsin, 53715
2/20/19
Ronni Hayon, MD
The “T” in LGBTQ: Providing Compassionate and Appropriate Care to TNG Patients

Learning Objectives:

Exploration of transphobia and privilege
Discuss key topics in medical and behavioral health as they relate to the care of TNG people
Develop concrete skills for providing affirming care to TNG people

Ronni Hayon, MD joined the Department of Family Medicine as an Assistant Professor in October 2012. She received her medical degree from Drexel University College of Medicine in Philadelphia and she completed her Family Medicine residency at the UW-Madison Family Medicine Residency Program. Following residency, Dr. Hayon completed a one-year Academic Fellowship with the Department of Family Medicine. Dr. Hayon has lectured extensively regionally and nationally about LGBTQ health issues, with a particular focus on transgender wellness.

The Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee). Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty. This educational series is open to the public and anyone is welcome to attend. Continue Medical Education units (CME’s) are available to eligible attendees.
Location:
Group Room A
UW Behavioral Health & Recovery
1102 South Park Street
Madison, WI 53715

Accreditation Statement:
In support of improving patient care, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statement:
The University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 CEUs or 1.0 hour.

Educational Conference: Dr. Michelle Poliak-Tunis, Department of Rehabilitative Medicine - Low Dose Naltrexone
2018-12-19 12:00 - 13:00 (America/Chicago) | Group Room A (4th Floor) | 1102 S Park St | UW Behavioral Health & Recovery, 1102 S Park Street, Suite 400, Madison, Wisconsin, 53715
The Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee). Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty. This educational series is open to the public and anyone is welcome to attend. Continue Medical Education units (CME’s) are available to eligible attendees.

Location:
Group Room A
UW Behavioral Health & Recovery
1102 South Park Street
Madison, WI 53715

12/19/18 – Dr. Michelle Poliak-Tunis, Department of Rehabilitative Medicine – Low Dose Naltrexone

Accreditation Statement
In support of improving patient care, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statement:
The University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Melissa DelBello, MD, MS | UW Psychiatry Grand Rounds
2018-11-30 12:00 - 13:15 (America/Chicago) | Webex
Neuropharmacology of Bipolar Disorder in Youth
Melissa Delbello, MD, MS, has served as professor and chair of the Department of Psychiatry and Behavioral Neuroscience since 2014. She joined the University of Cincinnati College of Medicine faculty in 2000 as an assistant professor of psychiatry and pediatrics. Dr. DelBello has served in several leadership roles in the Department of Psychiatry and Behavioral Neuroscience, including vice chair of clinical research since 2007 and co-director of the Division of Bipolar Disorders Research since 2004. She has also been co-director of the Mood Disorders Center at the UC Gardner Neuroscience Institute. A nationally recognized expert on child and adolescent mood disorders, Dr. DelBello has lectured and published extensively on bipolar disorder and served as principal or co-investigator of several NIH grants. She has been a member of the Neural Basis of Psychopathology, Addictions and Sleep Disorders Study Section of the Center for Scientific Review at the National Institutes of Health since 2009, most recently serving as chairperson for a term running from July 2012 through June 2014. Since 2012 she has chaired the Research Committee of the American Academy of Child and Adolescent Psychiatry. At UC Medical Center, she has served as medical director of the Resident Mood Medication Clinic since its launch in September 2013. She is co-director of the Mood Disorders Program at Cincinnati Children’s Hospital Medical Center. Dr. DelBello is a fellow of the American Academy of Child and Adolescent Psychiatry and also holds membership in the American Psychiatric Association, International Society for Bipolar Disorders and American College of Neuropsychopharmacology. A native of New York City, Dr. DelBello received her bachelor of science degree with honors from Cornell University and her medical degree with honors from the University of Rochester School of Medicine. She completed residencies in psychiatry at Cornell Medical Center (1995-96) and the UC College of Medicine (1996-98). In addition, she holds a master’s in epidemiology and biostatistics from UC.

Accreditation Statement
In support of improving patient care, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statement:
The University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Seminar: Noninvasive Brain Stimulation and Inhibitory Learning: Implications for the Behavioral Treatment of Anxiety and Related Disorders - Thomas Adams, PhD
2018-11-19 16:00 - 17:15 (America/Chicago) | WisPIC (HERI) Louis A. Holland Family Boardroom, 6001 Research Park Blvd, Madison, WI, 53719, United States
Noninvasive Brain Stimulation and Inhibitory Learning:
Implications for the Behavioral Treatment of Anxiety and Related Disorders
Thomas G. Adams Jr., Ph.D.
Clinical Psychologist
Assistant Professor
Department of Psychiatry
Yale University School of Medicine

Thomas Adams, PhD, received his bachelor’s degree from the University of Wisconsin-Milwaukee in 2006 and his Ph.D. in clinical psychology from the University of Arkansas in 2014 following the completion of a pre-doctoral internship within the traumatic stress track at the Charleston Consortium at the Medical University of South Carolina and the Ralph H. Johnson VA Medical Center. He joined the research faculty in Yale’s Department of Psychiatry following the completion of a NIMH-funded postdoctoral fellowship. He works primarily as a researcher at the Yale OCD Research Clinic and within the Clinical Neuroscience Division of the VA National Center for PTSD, and additionally provides instruction, clinical supervision, research mentorship, and private clinical services.

Educational Conference: Ketty Thertus MD - Updates in the Treatment of Pain in Patients with Psychiatric Disorders
2018-10-17 12:00 - 13:00 (America/Chicago)
The Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee). Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty. This educational series is open to the public and anyone is welcome to attend. Continue Medical Education units (CME’s) are available to eligible attendees.

Location:
Group Room A
UW Behavioral Health & Recovery
1102 South Park Street
Madison, WI 53715

10/17/18 – Ketty Thertus MD – Updates in the Treatment of Pain in Patients with Psychiatric Disorders

ACCREDITATION STATEMENT
In support of improving patient care, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CREDIT DESIGNATION STATEMENT:
The University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

6th Annual Update & Advances in Psychiatry Conference
2018-10-12 - 2018-10-13 | Monona Terrace Community and Convention Center, 1 John Nolan Drive, Madison, Wisconsin, 53703
For complete information, visit event webpage.
Brochure: 2018 Update & Advances in Psychiatry

PRESENTERS

VISITING FACULTY
Josepha A. Cheong, MD
Professor, Departments of Psychiatry and Neurology, University of Florida College of Medicine; Chief, Psychiatry Consult-Liaison Service, Malcom Randall VA Medical Center; Gainesville, FL
Charles DeBattista, DMH, MD
Professor of Psychiatry and Behavioral Sciences; Stanford University School of Medicine; Stanford, CA
Ellen Leibenluft, MD
Senior Investigator, NIMH Intramural Research Program; Bethesda, MD
Frances R. Levin, MD
Kennedy-Leavy Professor of Psychiatry at Columbia University Medical Center, New York, NY
Stephen R. Marder, MD
Daniel X. Freedman Professor of Psychiatry; Vice Chair for Education; Semel Institute for Neuroscience at UCLA; Director, VA Desert Pacific Mental Illness Research, Education, and Clinical Center; Los Angeles, CA
UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH FACULTY
Stuart W. Jones, MD
Clinical Assistant Professor of Psychiatry and Associate Residency Training Director
Ned H. Kalin, MD
Hedberg Professor and Chair of Psychiatry
Charlotte Ladd, MD
Clinical Associate Professor of Psychiatry
Michael J. Peterson, MD, PhD
Associate Professor (CHS); Director of Hospital Psychiatric Services
Ketty Thertus, MD
Assistant Professor of Psychiatry; Director, Adult Consultation Liaison Service
Art Walaszek, MD
Professor of Psychiatry

REGISTRATION INFORMATION

CONFERENCE FEES
$365 – Physicians (MD/DO) and PhDs
$265 – Other (Adjunct Clinical Faculty, PA, NP, RN, etc.)
$125 – UW SMPH/UW Health/UW Medical Foundation/VA/Meriter Faculty, Residents, and Staff
The conference fee includes the cost of tuition, continental breakfasts, lunch, refreshment breaks, and a nonrefundable processing fee of $50.

REGISTER/ENROLLMENT INFORMATION
Visit https://ce.icep.wisc.edu/2018-Annual-Update
• Select the “Register” tab
• Select login or register
• If you have a UW-Madison NetID: Select “Login with my UW-Madison NetID”
• If you do not have a UW-Madison NetID, please click on Visitor: Select “I already have an account” or “Create an account login and password”
• Follow any prompts to complete or update your profile information
• Once you are logged in, navigate back to:https://ce.icep.wisc.edu/2018-Annual-Update
• Click the “Register” tab, select your fee, complete any additional registration questions, and click, “Add to Cart”
• Select “Checkout” and follow the prompts to pay for the conference
Contact help@icep.wisc.edu if you need assistance.

NAMI Walk
2018-10-07 12:00 - 13:30 (America/Chicago) | Olin-Turville Park, 1156 Olin-Turville Ct, Madison, WI, 53715
The UW Department of Psychiatry invites you to take part in the 13th Annual NAMIWalks Dane County, to be held on Sunday, October 7th at Olin-Turville Park. Registration and festivities begin at 10:30am, and the Walk will start at Noon. Please come early so you can enjoy the refreshments, games and entertainment!
Join or donate to one of the UW Health Psychiatry Teams:

UW Health – UW Department of Psychiatry
UW Health – B6/5 Psychiatry
UW Health – Psychiatry Residents

Or visit the NAMIWalks Dane County webpage to create your own team, register, or make a donation!
By partnering with organizations like NAMI, we hope to raise awareness, reduce stigma, and improve the lives of millions of individuals and families impacted by mental illness by increasing access to affordable quality mental healthcare services & resources, advocating for policies that support mental health initiatives, and increasing funding for scientific research and the development of treatments that reduce suffering and increase well-being.

Ann E. Kelley Travel Award Reception
2018-09-24 17:00 - 18:30 (America/Chicago) | WisPIC, 6001 Research Park Blvd, Madison, WI, 53719
This small reception honors the legacy of Dr. Ann Kelley and this year’s recipient of the Anne E. Kelley Travel Award. The reception is not open to the public; it is intended for friends and family of Dr. Kelley, the award recipient, and other colleagues and researchers affiliated with the UW Department of Psychiatry and/or neuroscience programs.

Daniel Pine, MD | UW Psychiatry Grand Rounds
2018-09-13 12:00 - 13:15 (America/Chicago) | Webex
Using Neuroscience to Inform Clinical Thinking in Pediatric Anxiety

Dr. Daniel Pine is Chief, Section on Development and Affective Neuroscience, in the National Institute of Mental Health Intramural Research Program. Dr. Pine moved to this position in 2000, after 10 years of training, teaching, and research at Columbia University. Since graduating from medical school at the University of Chicago, Dr. Pine has been engaged continuously in research on pediatric mental disorders, as reflected in more than 500 peer-reviewed papers. Currently, his group examines the degree to which pediatric mood and anxiety disorders are associated with perturbed neural circuitry function. Dr. Pine served as the Chair of the Psychopharmacologic Drug Advisory Committee for the Food and Drug Administration, Chair of the Child and Adolescent Disorders Work Group for the DSM-5 Task Force, and President of the Society of Biological Psychiatry. He is a member of the Institute of Medicine of the National Academy of Sciences and has received many other awards.

ACCREDITATION STATEMENT
In support of improving patient care, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CREDIT DESIGNATION STATEMENT:
The University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Greenfield Memorial Lecture
2018-09-12 17:30 - 19:00 (America/Chicago) | Webex
Greenfield Memorial Lecture
Wednesday, Sept 12th 5:30-7pm
* Light refreshments will be served *
RSVP: sebastian@wisc.edu
CURRENT TREATMENTS FOR PEDIATRIC MOOD AND ANXIETY DISORDERS

Daniel Pine, M.D.
Chief, Emotion and Development Branch (E & D)
Chief, Section on Development and Affective Neuroscience (SDAN)
National Institute of Mental Health

Dr. Daniel Pine is Chief, Section on Development and Affective Neuroscience, in the National Institute of Mental Health Intramural Research Program. Dr. Pine moved to this position in 2000, after 10 years of training, teaching, and research at Columbia University. Since graduating from medical school at the University of Chicago, Dr. Pine has been engaged continuously in research on pediatric mental disorders, as reflected in more than 500 peer-reviewed papers. Currently, his group examines the degree to which pediatric mood and anxiety disorders are associated with perturbed neural circuitry function. Dr. Pine served as the Chair of the Psychopharmacologic Drug Advisory Committee for the Food and Drug Administration, Chair of the Child and Adolescent Disorders Work Group for the DSM-5 Task Force, and President of the Society of Biological Psychiatry. He is a member of the Institute of Medicine of the National Academy of Sciences and has received many other awards.

ABOUT NORMAN GREENFIELD AND THE GREENFIELD LECTURE
This annual lecture honors the legacy of Norman S. Greenfield, former Professor of Psychiatry and Associate Director and co-founder of the Wisconsin Psychiatric Institute. The lecture fosters educational efforts related to understanding neuroplastic mechanisms underlying change with effective treatments, especially psychotherapy.
Dr. Greenfield played a key role in fostering early scientific investigations into the role of psychophysiological correlates of psychological disorders and the processes involved in personality change, as exemplified by his books “Psychoanalysis and Current Biological Thought” and “The Handbook of Psychophysiology.”
Additionally, Dr. Greenfield was very dedicated to the supervision of psychiatry residents and preparing them to effectively integrate psychotherapy with pharmacology in their treatment of patients. The early values he brought to the University of Wisconsin Department of Psychiatry, using rigorous scientific methods to integrate psychology with psychiatry to improve the lives of those suffering from mental illness, continue today as the Department of Psychiatry’s guiding principles.

Accreditation Statement
In support of improving patient care, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statement:
The University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Educational Conference: Kavita Poddar - State of the Heart – Diet and Nutrition Perspective
2018-09-12 12:00 - 13:00 (America/Chicago) | Group Room A (4th Floor) | 1102 S Park St | UW Behavioral Health & Recovery, 1102 S Park Street, Suite 400, Madison, Wisconsin, 53715
The Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee). Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty. This educational series is open to the public and anyone is welcome to attend. Continue Medical Education units (CME’s) are available to eligible attendees.

Location:
Group Room A
UW Behavioral Health & Recovery
1102 South Park Street
Madison, WI 53715

9/12/18 – Kavita Poddar – State of the Heart – Diet and Nutrition Perspective

Accreditation Statement
In support of improving patient care, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statement:
The University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

SEMINAR: Sleep Spindle Deficits in Schizophrenia: Established Findings, New Data, and Future Directions
2018-09-10 15:00 - 16:00 (America/Chicago) | Webex
Sleep Spindle Deficits in Schizophrenia:
Established Findings, New Data, and Future Directions

Dr. Ferrarelli’s primary research interests involve the utilization of neuroimaging and neurophysiological techniques, including high density (hd)-EEG, fMRI and Transcranial Magnetic Stimulation (TMS) to better understand the neurobiology of major psychiatric disorders, and especially schizophrenia (SCZ). Dr. Ferrarelli earned his MD and PhD in psychiatry at the Catholic University of the Sacred Heart in Rome. At the University of Wisconsin-Madison, and while completing his residency at Western Psychiatric Institute and Clinic at Pittsburgh, he studied the alterations in neuronal circuits contributing to SCZ and related disorders both during wakefulness and sleep. In wakefulness, he demonstrated a reduction of TMS-evoked fast oscillations in frontal areas in SCZ patients relative to healthy control (HC). In sleep, he established marked deficits in sleep spindles, waxing/waning, 12-16 Hz oscillations that represent a hallmark of Stage 2 Non-Rapid Eye Movement (N2) Sleep, in SCZ compared to both HC and other psychiatric patients. Dr. Ferrarelli, who is currently an Assistant Professor, an Attending Physician, as well as the Director of the Sleep and Schizophrenia program at the Department of Psychiatry at Pittsburgh, will now extend those lines of research to early course SCZ as well as individuals at clinical high risk for psychosis.

Note: This seminar is not open to the public. It is intended for UW faculty and researchers involved in Psychiatric and Neuroscientific investigations related to sleep and schizophrenia. If you would like to attend, simply check with the organizer: sebastian@wisc.edu

Deadline to Apply for Ann E. Kelley Travel Award
2018-09-01
The Ann E. Kelley Fellowship in Behavioral Neuroscience honors the legacy of Dr. Kelley and supports the training of future generations of behavioral neuroscientists that embody her passion for understanding the brain with the ultimate goal of using this knowledge to reduce human suffering.
The UW Department of Psychiatry invites University of Wisconsin graduate students presenting a paper or poster relevant to behavioral neuroscience at the Society for Neuroscience’s (SfN) annual meeting in San Diego on November 03-07, 2018 to apply for the Ann E. Kelley Travel Award. The winner will receive an award of $600 to assist with travel expenses.
Applications will be accepted from August 1, 2018 to September 1, 2018. This is a competitive award; the entries will be judged by a committee of UW Department of Psychiatry faculty members. The winner will be notified by September 15, 2018 and a reception will be held at WisPIC on Monday, September 24, 2018 from 5:00pm – 6:30pm.
Please submit your application to sebastian@wisc.edu in the form of one PDF file that contains the following documents in this exact order:

Application Form
Abstract
Personal statement of research interest (one page limit)
Current CV
Letter from your mentor that includes a statement of student merit

Questions can be directed to: sebastian@wisc.edu

Educational Conference: Melody Cole, Department of Staff Education - Motivational Interviewing (Part 2)
2018-08-15 12:00 - 13:00 (America/Chicago) | Group Room A (4th Floor) | 1102 S Park St | UW Behavioral Health & Recovery, 1102 S Park Street, Suite 400, Madison, Wisconsin, 53715
The Educational Conference series is a series of lectures designed to provide clinically useful information to the practicing psychiatrist (faculty or trainee). Every 1 to 2 months an intra- or extra-departmental speaker is invited to speak on a topic of interest selected by current faculty. This educational series is open to the public and anyone is welcome to attend. Continue Medical Education units (CME’s) are available to eligible attendees.

Location:
Group Room A
UW Behavioral Health & Recovery
1102 South Park Street
Madison, WI 53715

3/7/18 – Melody Cole, Department of Staff Education – Motivational Interviewing (Part 1)
8/15/18 – Melody Cole, Department of Staff Education – Motivational Interviewing (Part 2)

Accreditation Statement
In support of improving patient care, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statement:
The University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Andrew H. Miller, MD | UW Psychiatry Grand Rounds
2018-08-03 12:00 - 13:15 (America/Chicago) | Webex
Inflammation and Depression: Mechanisms, Mediators and Therapeutic Implications
Andrew Miller, MD is William P. Timmie Professor of Psychiatry and Behavioral Sciences at the Emory University School of Medicine in Atlanta, Georgia. He is also the Vice Chair for Research in the Department of Psychiatry and Behavioral Sciences and Director of the Emory Behavioral Immunology Program. Finally, Dr. Miller is the co-leader of the Cancer Prevention and Control Research Program Research at the Winship Cancer Institute. Dr. Miller is an internationally recognized leader in the area of brain-immune interactions as they relate to depression in medically healthy as well as medically ill patients including patients with cancer. His work has demonstrated that during immune activation, inflammatory cytokines can access the brain and interact with the metabolism of dopamine and glutamate, while altering neurocircuits in the brain relevant to motivation and reward as well as anxiety and alarm. Dr. Miller has also studied the impact of cytokines on neuroendocrine regulation and sleep including the study of the specific signal transduction pathways involved. Additionally, Dr. Miller and his group conducted the first clinical trial examining the efficacy of a cytokine antagonist for the treatment of depression. He has produced over 200 scholarly publications and edited a book entitled Depressive Disorders and Immunity. Dr. Miller’s research awards include the Curt Richter Award from the International Society of Psychoneuroendocrinology and the Norman Cousins Award from the Psychoneuroimmunology Research Society. Aside from his research endeavors, Dr. Miller has won numerous teaching and mentoring awards and is a Board Certified Psychiatrist and past examiner for the American Board of Psychiatry and Neurology.

Accreditation Statement
In support of improving patient care, the University of Wisconsin-Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statement:
The University of Wisconsin-Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

“Towards Computational Phenotypes in Psychiatry” - Amy L. Cochran, PhD
2018-07-20 11:00 - 12:00 (America/Chicago) | Webex
“Towards Computational Phenotypes in Psychiatry”
Amy L. Cochran, PhD
Research Associate
Biostatistics and Medical Informatics
University of Wisconsin

Friday July 20th – 11 AM – 12 noon
WISPIC Commons Room

Amy L. Cochran, Ph.D completed her Ph.D. in Applied Mathematics from Cornell University in 2013 and was a T.H. Hildebrandt Research Assistant Professor in the Mathematics Department at the University of Michigan. She is now a NIMH K01 awardee in Biostatistics and Medical Informatics at the University of Wisconsin. Her research interests lie at the intersection of mathematics and psychiatry. She relies on a broad suite of applied math techniques, such as modeling, simulation, and statistics, to tackle problems in psychiatry. She is interested in describing (precisely with mathematics) mood changes on an individual patient basis. She hopes that this information can lead to personalized treatment of bipolar disorder which accounts for a patient’s unique illness course. Her most recent project looks to systematically determine basic principles of how mood changes in bipolar I patients, e.g. whether mood fluctuates rhythmically. Future work aims to use smart-phone technology and mathematics to track mood in bipolar patients more precisely and in real time. Amy is one of three editors of the book Computational Neurology and Psychiatry.

Bunmi O. Olatunji, PhD
2018-06-08 12:00 - 13:15 (America/Chicago) | Webex
The Psychopathology of Disgust in Obsessive-Compulsive Disorder
Bunmi O. Olatunji, PhD is Professor in the Department of Psychology and Psychiatry at Vanderbilt University where he also serves as the Director of Clinical Training. He is Associate Editor of the Journal of Consulting and Clinical Psychology and currently serves on the editorial boards of Behavior Therapy, International Journal of Cognitive Therapy, Journal of Obsessive-Compulsive and Related Disorders, Psychological Bulletin, Psychological Assessment, and Psychotherapy. He has published more than 160 journal articles and book chapters, and has participated in more than 100 conference presentations. He is co-author of the book “10-minute CBT: Cognitive behavioral interventions for the brief medication visit” published by Oxford Press and co-editor of the book “Disgust and its disorders: Assessment, theory, and treatment” published by the American Psychological Association.
As Director of the Emotion and Anxiety Research Laboratory at Vanderbilt University, his primary research interest involves multilevel examination of cognitive behavioral theory, assessment, and therapy for anxiety disorders. He is currently adopting an experimental psychopathology framework to examine the role of basic emotions, especially disgust, as they relate to the assessment, etiology, and maintenance of anxiety-related disorders. His research has been funded by the National Institute of Health and the Anxiety Disorders Association of America. For his research and professional efforts, he had been the recipient of the American Psychological Association (APA) Division 12 David Shakow Early Career Award for Distinguished Scientific Contributions to Clinical Psychology, the Association for the Advancement of Behavioral and Cognitive Therapies New Researcher Award, and the APA Division 12 Theodore Blau Early Career Award for Distinguished Professional Contributions to Clinical Psychology. He was also the recent recipient of the APA Distinguished Scientific Awards for an Early Career Contribution to Psychology. This award recognizes excellent psychologists who are at early stages of their research careers.

Grand Rounds: Mary Phillips, MD, MD
2018-04-27 12:00 - 13:15 (America/Chicago) | Webex
Multimodal Neuroimaging – Neural Circuits and Mood Disorders:
Toward Neural Biomarkers for Novel Interventions

Mary Phillips, MD, MD is the Pittsburgh Foundation-Emmerling Endowed Chair in psychotic Disorders, and Professor in Psychiatry and Clinical and Translational Science in the University of Pittsburgh. She heads the Clinical and Translational Affective Neuroscience Program in the Department of Psychiatry at the University of Pittsburgh. Dr. Phillips’ research focuses on using multimodal neuroimaging techniques to elucidate functional and structural abnormalities in emotion processing, reward processing and emotional regulation circuitries that are associated with specific psychiatric disorders, and symptom dimensions in individuals with mood and anxiety disorders. Her research also focuses on identifying the neurodevelopmental trajectories in these circuitries that are associated with the development of such disorders in youth and infants, and the extent to which these neuroimaging techniques can identity biomarkers reflecting underlying pathophysiologic processes that denote future risk for these disorders in as yet unaffected youth. Her more recent work examines how neuromodulation techniques can be targeted on identified neural biomarkers of mood disorders, as a step toward developing new interventions for individuals with these disorders. She works in collaboration with basic neuroscientists in translational studies of neural circuitry abnormalities in these disorders.
Dr. Phillips trained in Medicine at Cambridge University, UK, and in Psychiatry at the Maudsley Hospital and the Institute of Psychiatry, King’s College, University of London, UK. She joined the Department of Psychiatry at the University of Pittsburgh as a full-time faculty member in July, 2005. In 2005, Dr. Phillips became a member of the American College of Neuropsychopharmacology; in 2006, she was awarded the Nellie Blumenthal Independent Investigator Award by the Brain and Behavior Research Foundation (National Alliance for Research in Schizophrenia and Depression); in 2012, became a Fellow of the American College of Neuropsychopharmacology; and, in 2014, she became a member of the American Society of Clinical Investigation and received the Joel Elkes Research Prize of the American College of Neuropsychopharmacology. In 2018, she became President Elect of the Society of Biological Psychiatry, has served on the Membership Committee of the American College of Neuropsychopharmacology, and on Program Committees of both the Society of Biological Psychiatry and the American College of Neuropsychopharmacology. In 2018, she was elected to the Scientific Council of the Brain and Behavior Research Foundation, and received the Brain and Behavior Research Foundation Colvin Prize for research in mood disorders in 2018.
Dr. Phillips has received research funding awards from the National Institute of Mental Health and the Brain and Behavior Research Foundation in the U.S., and the Medical Research Council and the Wellcome Trust in the UK. Dr. Phillips has mentored over 60 junior investigators, including being mentor to 11 K awardees, has extensive national and international collaborations, and has authored or co-authored more than 300 publications.

Wisconsin Symposium on Emotion - Day 2
2018-04-20 07:00 - 13:00 UTC | Union South, 1308 W Dayton St, Madison, WI, 53715
“Order and Disorder in the Emotional Brain”
Union South – Marquee Theatre
Thursday, April 19th – Friday April 20th
Speakers:
Elisabeth Binder, M.D, Ph.D.
Kristen Brennand, Ph.D.
Frances Anne Champagne, Ph.D.
Kevin LaBar, Ph.D.
Martin Paulus, M.D.
